Xerox reached a settlement with a major shareholder granting him special shares in the copier maker’s two businesses after its split. The company also reported a bigger-than-expected decline in revenue but still swung to a profit.
The backlash against the high and rising cost of medicines may be cracking the foundation of the convoluted U.S. drug-pricing system, hitting the bottom lines of manufacturers and industry middlemen that have benefited from increases.
A high-profile Silicon Valley startup nixed its plan to market an aftermarket kit that could be installed in some cars to take over driving, after U.S. regulators began asking questions about the product.
Anheuser-Busch InBev NV cut its revenue forecast for the year after the world’s largest brewer reported weak third-quarter results, dragged down by surging financing costs and slumping sales in Brazil and the U.S.